📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Neuronex

1.1 - Company Overview

Neuronex Logo

Neuronex

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of development-stage pharmaceutical drug development focused on treatments for central nervous system (CNS) diseases and disorders. Combines clinical expertise with thorough knowledge of the drug development process in a nimble, entrepreneurial environment to achieve rapid success in obtaining approvals.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Neuronex

Arcion Therapeutics Logo

Arcion Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology research and development focused on developing treatments for chronic pain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arcion Therapeutics company profile →
SwanBio Therapeutics Logo

SwanBio Therapeutics

HQ: United States Website
  • Description: Provider of gene therapy focused on genetically defined therapies for neurological disorders. Offerings include SBT101, a candidate for adrenomyeloneuropathy targeting ABCD1 via AAV9; pipeline development in spinal cord-related indications; clinical trials, including a Phase 1/2 study of SBT101 and natural history studies of AMN; and patient and family resources, including trial information and compassionate use policies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SwanBio Therapeutics company profile →
Coaxia Logo

Coaxia

HQ: United States Website
  • Description: Provider of medical device research and development focused on therapy and treatment solutions for cerebral ischemia; based in Minneapolis, MN.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Coaxia company profile →
Avanir Pharmaceuticals Logo

Avanir Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical medicines for central nervous system disorders, focused on high unmet medical need. Offers Nuedexta, a medication used to treat pseudobulbar affect (PBA), characterized by sudden, uncontrollable episodes of crying or laughing. Extensively invests in its pipeline and is dedicated to advancing medicines that can substantially improve patients' lives.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avanir Pharmaceuticals company profile →
Neumora Logo

Neumora

HQ: United States Website
  • Description: Provider of clinical-stage investigational therapies for brain diseases, conducting trials to evaluate new treatments. Portfolio includes navacaprant, an investigational oral Phase 3 medication for major depressive disorder that modulates dopamine and reward processing pathways, plus NMRA-NLRP3 and NMRA-GCASE programs for neurodegenerative diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Neumora company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Neuronex

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Neuronex

2.2 - Growth funds investing in similar companies to Neuronex

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Neuronex

4.2 - Public trading comparable groups for Neuronex

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Neuronex

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Neuronex

What does Neuronex do?

Neuronex is a provider of development-stage pharmaceutical drug development focused on treatments for central nervous system (CNS) diseases and disorders. Combines clinical expertise with thorough knowledge of the drug development process in a nimble, entrepreneurial environment to achieve rapid success in obtaining approvals.

Who are Neuronex's competitors?

Neuronex's competitors and similar companies include Arcion Therapeutics, SwanBio Therapeutics, Coaxia, Avanir Pharmaceuticals, and Neumora.

Where is Neuronex headquartered?

Neuronex is headquartered in United States.

How many employees does Neuronex have?

Neuronex has 1,000 employees 🔒.

When was Neuronex founded?

Neuronex was founded in 2010 🔒.

What sector and industry vertical is Neuronex in?

Neuronex is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Neuronex

Who are the top strategic acquirers in Neuronex's sector and industry

Top strategic M&A buyers and acquirers in Neuronex's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Neuronex?

Top strategic M&A buyers groups and sectors for Neuronex include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Neuronex's sector and industry vertical

Which are the top PE firms investing in Neuronex's sector and industry vertical?

Top PE firms investing in Neuronex's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Neuronex's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Neuronex's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Neuronex's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Neuronex include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Neuronex's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Neuronex?

The key public trading comparables and valuation benchmarks for Neuronex include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Neuronex for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Neuronex with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Neuronex's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Neuronex with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Neuronex's' sector and industry vertical?

Access recent funding rounds and capital raises in Neuronex's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Neuronex